Evaluation of Transfection Protocols for Unmodified and Modified Peptide Nucleic Acid (PNA) Oligomers
Overview
Molecular Biology
Authors
Affiliations
We have compared the efficacy of different transfection protocols reported for peptide nucleic acid (PNA) oligomers. A precise evaluation of uptake efficacy was achieved by using a positive readout assay based on the ability of a PNA oligomer to correct aberrant splicing of a recombinant luciferase gene. The study comprised transfection of PNA conjugated to acridine, adamantyl, decanoic acid, and porphyrine (acr-PNA, ada-PNA, deca-PNA, and por-RNA, respectively) and unmodified PNA partially hybridized to a DNA oligomer (PNA/DNA cotransfection). Furthermore, the effect of conjugation to a nuclear localization signal (NLS) was evaluated as part of the PNA/DNA cotransfection protocol. Transfection of the tested PNAs was systematically optimized. PNA/DNA cotransfection was found to produce the highest luciferase activity, but only after careful selection of the DNA oligonucleotide. Both a cationic lipid, Lipofectamine, and a nonliposomal cationic polymer, polyethylenimine (PEI, ExGen 500), were efficient transfection reagents for the PNA/DNA complex. However, Lipofectamine, in contrast to PEI, showed severe side effects, such as cytotoxicity. acr-PNA, ada-PNA, and por-PNA were transfectable with efficacies between 5 and 10 times lower than that seen with PNA/DNA cotransfection. Conjugation of PNA to NLS had no effect on PNA/DNA cotransfection efficacy. An important lesson from the study was the finding that because of uncontrollable biologic variations, even optimal transfection conditions differed to a certain extend from experiment to experiment in an unpredictable way.
Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector.
Finotti A, Gasparello J, Casnati A, Corradini R, Gambari R, Sansone F Methods Mol Biol. 2020; 2211:123-143.
PMID: 33336275 DOI: 10.1007/978-1-0716-0943-9_10.
GFP Knockdown by Cationic Nanogel-siRNA Polyplexes.
Shrivats A, Mishina Y, Averick S, Matyjaszewski K, Hollinger J Bioengineering (Basel). 2016; 2(3):160-175.
PMID: 27280121 PMC: 4894740. DOI: 10.3390/bioengineering2030160.
Antisense peptide nucleic acid-functionalized cationic nanocomplex for in vivo mRNA detection.
Shen Y, Shrestha R, Ibricevic A, Gunsten S, Welch M, Wooley K Interface Focus. 2014; 3(3):20120059.
PMID: 24427537 PMC: 3638413. DOI: 10.1098/rsfs.2012.0059.
Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA.
Jarver P, Coursindel T, El Andaloussi S, Godfrey C, Wood M, Gait M Mol Ther Nucleic Acids. 2013; 1:e27.
PMID: 23344079 PMC: 3390225. DOI: 10.1038/mtna.2012.18.
Targeting pre-miRNA by peptide nucleic acids: a new strategy to interfere in the miRNA maturation.
Avitabile C, Saviano M, DAndrea L, Bianchi N, Fabbri E, Brognara E Artif DNA PNA XNA. 2012; 3(2):88-96.
PMID: 22699795 PMC: 3429535. DOI: 10.4161/adna.20911.